Vera Therapeutics elevates Matt Skelton to Chief Commercial Officer, signaling a strategic shift towards commercialization as its lead drug candidate, atacicept for IgA nephropathy, undergoes FDA Priority Review with a PDUFA date set for July 2026.
General Mills faces a pivotal moment as it appoints a new independent director and updates governance bylaws, while simultaneously expanding a voluntary recall of Pillsbury Pizza Pops in Canada over potential E. coli contamination. These parallel developments underscore the balancing act between strategic oversight and operational risk management for the consumer staples giant.
Investment firm Giverny Capital has established a significant, long-term position in Watsco, the leading U.S. HVAC distributor. The move underscores institutional confidence in the company's entrenched market position and its leverage to enduring trends in building climate control.
Bloom Energy secures a multi-billion dollar, multi-year agreement with American Electric Power, marking its largest commercial deal to date. The partnership promises a major rollout of Bloom's fuel cell technology but arrives as the company's stock faces intense scrutiny over its recent meteoric rise and long-term valuation.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its injectable weight loss therapies, alongside forging two new research collaborations targeting hearing loss and autoimmune diseases, as its stock continues a meteoric rise.
Once a popular and practical finish, pebbledash render is now seen by many buyers as a dated eyesore that can knock thousands off a property's price. But is removal always the answer?
New data reveals companies embracing structured flexibility are growing significantly faster and attracting deeper talent pools than their office-mandate rivals, reshaping the post-pandemic competitive landscape.
With its Albertsons merger blocked, Kroger is pivoting its growth strategy, channeling hundreds of millions into expanding its large-format Marketplace stores across Indiana, Texas, and West Virginia.
Visa and UnionPay International announce a strategic partnership to enable real-time, cross-border payments directly to debit cards in China, targeting one of the world's largest remittance corridors by 2026.
Amnesty International warns that new bills advancing in the Knesset would disproportionately target Palestinians, marking a stark reversal of Israel's long-standing de facto ban on capital punishment and deepening systemic discrimination.
As clinical-stage biotech Alumis sees its stock price skyrocket on optimism for its autoimmune disease pipeline, one investment fund has made a contrarian move, selling its entire position just before a major rally.
The Gemini alliance, comprising Maersk and Hapag-Lloyd, announces a phased return to the Suez Canal route with military protection, marking a cautious shift after months of Houthi-related disruptions to global trade.
BellRing Brands reports a solid Q1 2026, beating expectations but narrows full-year sales guidance amid heightened promotional activity from insurgent brands in the protein shake market. CEO Darcy Horn Davenport announces her retirement, marking the end of a 17-year tenure that saw the company grow from $20 million to a $2.3 billion global business.
Specialty materials leader ATI reports robust Q4 and full-year 2025 results, exceeding guidance on strong demand for proprietary aerospace alloys and defense systems. With a new CFO at the helm, the company projects 16% EBITDA growth for 2026, fueled by long-term agreements and strategic capacity investments.
The Walt Disney Company has appointed Josh D'Amaro, the architect behind its booming parks and experiences division, as its new chief executive, succeeding Bob Iger and charting a course through a turbulent media landscape.
McDonald's re-enters the top 10 of Entrepreneur's Franchise 500, climbing from 22nd place, driven by a strategic return to value-focused offerings like the $5 meal deal and the Snack Wrap.
The FDA launches a new program to fast-track reviews for strategically important drug manufacturing facilities. In separate developments, AstraZeneca faces a setback for a lupus drug formulation, while Acadia Pharmaceuticals receives a negative signal from European regulators for its Rett syndrome therapy.
The Swedish EV maker bolsters its financial position with a major cash injection from two Asian financial giants, marking its second significant funding round in two months on the heels of a 34% sales jump.
Jean-Baptiste Santoul, a Ferrero veteran, takes the reins at the newly acquired WK Kellogg, pledging to accelerate growth and navigate the challenges facing the North American cereal market.
Major fintech firms like Stripe, PayPal, and Affirm are actively pursuing state and federal banking licenses, seeking not just cost savings but greater control, regulatory simplicity, and a direct line to core financial infrastructure.
